Evidence map›Paper›PMID 41476721›Full record

ArticleFrontiers in dental medicine2025

Oral tolerance, a potential driver of systemic disease risk in periodontal patients.

Alan E Hubbs

Abstract read
In one paragraph

Article in Frontiers in dental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Alan E HubbsRare Opportunities LLC, Rockville, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periodontal disease is a recognized risk factor for sepsis, infective endocarditis, and cardiovascular disease. Oral bacteria, including viridans group of Streptococci, abundant in healthy oral microbiota, are frequently implicated in bacteremia and chronic inflammation, both contributing factors to systemic diseases. Yet the immunological mechanisms linking oral and systemic disease remain incompletely defined. This article proposes that "oral tolerance"-the immune system's suppression of responses to antigens repeatedly encountered via the oral route-may heighten susceptibility to systemic diseases, by impairing early systemic innate immune engagement with oral bacteria entering the bloodstream. Specifically, tolerogenic-signaling by gut-associated lymphoid tissue may condition circulating innate immune cells toward a regulatory phenotype, delaying effective pathogen clearance and promoting cytokine disorientation. This brief review outlines mechanistic insights, explores microbial influences, and suggests experimental approaches, aiming to advance research in oral-systemic health.

Indexed as

cardiovascular diseasechronic inflammatory diseaseGALTgut-associated lymphoid tissueimmune switchinginfective endocarditisoral toleranceperiodontitis

Identifiers

PMID41476721
PMCPMC12748255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.